Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 10
Submit an article Journal homepage
145
Views
8
CrossRef citations to date
0
Altmetric
Letters to the Editor

The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide±rituximab: results of a randomized phase II trial

Heather E. Eve Department of Haematology, Derriford Hospital, Plymouth, Devon, UK
,
Jo Gambell Cancer Research UK and UCL Cancer Trials Centre, London, UK
,
Paul Smith Cancer Research UK and UCL Cancer Trials Centre, London, UK
,
Wendi Qian Cancer Research UK and UCL Cancer Trials Centre, London, UK
&
Simon A. J. Rule Department of Haematology, Derriford Hospital, Plymouth, Devon, UKCorrespondence[email protected]
Pages 1709-1711 | Received 01 Jun 2009, Accepted 14 Jul 2009, Published online: 08 Oct 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

David Salek, Pavla Vesela, Ludmila Boudova, Andrea Janikova, Pavel Klener, Samuel Vokurka, Milada Jankovska, Robert Pytlik, David Belada, Jan Pirnos, Mojmir Moulis, Roman Kodet, Michal Michal, Eva Janousova, Jan Muzik, Jiri Mayer & Marek Trněný. (2014) Retrospective analysis of 235 unselected patients with mantle cell lymphoma confirms prognostic relevance of Mantle Cell Lymphoma International Prognostic Index and Ki-67 in the era of rituximab: long-term data from the Czech Lymphoma Project Database. Leukemia & Lymphoma 55:4, pages 802-810.
Read now
Stephen E. Spurgeon, Talia Pindyck, Craig Okada, Yiyi Chen, Zunqiu Chen, Elana Mater, Kamal Abbi & Elliot M. Epner. (2011) Cladribine plus rituximab is an effective therapy for newly diagnosed mantle cell lymphoma. Leukemia & Lymphoma 52:8, pages 1488-1494.
Read now

Articles from other publishers (6)

Lavanya Lokhande, Venera Kuci Emruli, Arne Kolstad, Martin Hutchings, Riikka Räty, Mats Jerkeman & Sara Ek. (2020) Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk. BMC Cancer 20:1.
Crossref
Dai Chihara, Naoko Asano, Ken Ohmachi, Tomohiro Kinoshita, Masataka Okamoto, Yoshinobu Maeda, Ishikazu Mizuno, Kosei Matsue, Toshiki Uchida, Hirokazu Nagai, Momoko Nishikori, Shigeo Nakamura, Michinori Ogura & Ritsuro Suzuki. (2015) Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan. British Journal of Haematology 170:5, pages 657-668.
Crossref
Eva HosterWolfram KlapperOlivier HermineHanneke C. Kluin-NelemansJan WalewskiAchiel van HoofMarek TrnenyChristian H. GeislerFrancesco Di RaimondoMichal SzymczykStephan StilgenbauerCatherine ThieblemontMichael HallekRoswitha ForstpointnerChristiane PottVincent RibragJeanette DoorduijnWolfgang HiddemannMartin H. DreylingMichael Unterhalt. (2014) Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network. Journal of Clinical Oncology 32:13, pages 1338-1346.
Crossref
M. Dreyling, C. Thieblemont, A. Gallamini, L. Arcaini, E. Campo, O. Hermine, J.C. Kluin-Nelemans, M. Ladetto, S. Le Gouill, E. Iannitto, S. Pileri, J. Rodriguez, N. Schmitz, A. Wotherspoon, P. Zinzani & E. Zucca. (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Annals of Oncology 24:4, pages 857-877.
Crossref
Eva Hoster. (2011) Prognostic Relevance of Clinical Risk Factors in Mantle Cell Lymphoma. Seminars in Hematology 48:3, pages 185-188.
Crossref
Stephen D. Smith, Eric Hsi, Brian Bolwell, Brad Pohlman, Robert Dean, Meagan Effinger, Amanda Maggiotto & John Sweetenham. (2010) Validation of the mantle cell lymphoma international prognostic index: A single‐center retrospective analysis. American Journal of Hematology 85:6, pages 454-456.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.